1. Home
  2. TOUR vs ICCC Comparison

TOUR vs ICCC Comparison

Compare TOUR & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tuniu Corporation

TOUR

Tuniu Corporation

HOLD

Current Price

$5.10

Market Cap

73.1M

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$10.65

Market Cap

75.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOUR
ICCC
Founded
2006
1982
Country
China
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.1M
75.8M
IPO Year
2014
1995

Fundamental Metrics

Financial Performance
Metric
TOUR
ICCC
Price
$5.10
$10.65
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
16.9K
23.9K
Earning Date
06-11-2026
05-15-2026
Dividend Yield
17.12%
N/A
EPS Growth
N/A
53.85
EPS
N/A
0.21
Revenue
N/A
$26,493,169.00
Revenue This Year
$17.30
N/A
Revenue Next Year
$14.00
N/A
P/E Ratio
$87.34
$49.00
Revenue Growth
N/A
51.64
52 Week Low
$0.56
$4.52
52 Week High
$7.79
$11.16

Technical Indicators

Market Signals
Indicator
TOUR
ICCC
Relative Strength Index (RSI) 46.45 58.26
Support Level $4.53 $9.27
Resistance Level $6.50 $10.75
Average True Range (ATR) 0.29 0.42
MACD 0.00 0.05
Stochastic Oscillator 40.17 54.45

Price Performance

Historical Comparison
TOUR
ICCC

About TOUR Tuniu Corporation

Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: